Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
1.170
-0.030 (-2.50%)
Feb 21, 2025, 4:00 PM EST - Market closed
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $83.72 million as of February 21, 2025. Its market cap has decreased by -12.74% in one year.
Market Cap
83.72M
Enterprise Value
87.52M
1-Year Change
-12.74%
Ranking
Category
Stock Price
1.17
Market Cap Chart
Since December 8, 2022, Citius Oncology's market cap has decreased from $90.21M to $83.72M, a decrease of -7.20%. That is a compound annual growth rate of -3.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 83.72M | 1.74% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |